Acute hormonal changes after IV citalopram and treatment response in OCD

Psychopharmacology

Volumn 193, Issue 4, 2007, Pages 487-494

  Corregiari, Fábio M ^a   Gattaz, Wagner F ^a   Bernik, Márcio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Citalopram; Cortisol; Growth hormone; Obsessive compulsive disorder; Prognosys; Prolactin; Serotonin; Serotonin reuptake inhibitors; Therapeutic response

Indexed keywords

CITALOPRAM; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; FEMALE; FRIEDMAN TEST; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; TREATMENT RESPONSE; VOLUNTEER;

ADULT; CASE-CONTROL STUDIES; CITALOPRAM; FEMALE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PROLACTIN; SEROTONIN UPTAKE INHIBITORS;

EID: 34447634521     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0793-0     Document Type: Article

References (28)

1. Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8(3):391-401, Sep
2. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001) Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology (Berl) 155(3):323-326, May
3. Bijak M, Zahorodna A, Tokarski K (2001) Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation. Naunyn Schmiedebergs Arch Pharmacol 363(5):491-498, May
4. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45(2):177-185, Feb
5. Dalton GL, Lee MD, Kennett GA, Dourish CT, Clifton PG (2004) mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology 46(5):663-671, Apr
6. Denys D (2006) Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatr Clin North Am 29(2):553-584, Jun
7. Dremencov E, Gur E, Lerer B, Newman ME (2002) Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus. Prog Neuropsychopharmacol Biol Psychiatry 26(6):1029-1034, Oct
8. Fineberg NA, Roberts A, Montgomery SA, Cowen PJ (1997) Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine. Br J Psychiatry 171:280-282, Sep
9. Flory JD, Manuck SB, Perel JM, Muldoon MF (2004) A comparison of d, l-fenfluramine and citalopram challenges in healthy adults. Psychopharmacology (Berl) 174(3):376-380, Jul
10. Graeff FG (2004) Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28(3):239-259, May
11. Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J (2004) Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan. Neuropsychobiology 50(3):200-205
12. Gur E, Dremencov E, Lerer B, Newman ME (2001) Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies. Eur J Pharmacol 411(1-2):115-122, Jan 5
13. Hawken ER, Owen JA, Van Vugt D, Delva NJ (2006) Effects of oral racemic citalopram on neuroendocrine responses. Prog Neuropsychopharmacol Biol Psychiatry 30(4):694-700, Jun
14. Henning J, Netter P (2002) Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests. Int J Neuropsychopharmacol 5(1):67-71, Mar
15. Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR (1988) Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. Am J Psychiatry 145(8):1015-1017, Aug
16. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR (1992) Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m- chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49(1):21-28, Jan
17. Kapitany T, Schindl M, Schindler SD, Hesselmann B, Fureder T, Barnas C, Sieghart W, Kasper S (1999) The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res 88(2):75-88, Nov 8
18. Karten YJ, Nair SM, van Essen L, Sibug R, Joels M (1999) Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci U S A 96(23):13456-13461, Nov 9
19. Khanna S, John JP, Reddy LP (2001) Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder. Psychoneuroendocrinology 26(2):209-223
20. Lesch KP, Hoh A, Schulte HM, Osterheider M, Muller T (1991) Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology (Berl) 105(3):415-420
21. Lowe SL, Yeo KP, Teng L, Soon DK, Pan A, Wise SD, Peck RW (2006) l-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI. Psychoneuroendocrinology 31(4):473-484
22. Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG (1992) Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. Br J Psychiatry 161:517-521
23. Monteleone P, Catapano F, Di Martino S, Ferraro C, Maj M (1997) Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment. Br J Psychiatry 170:554-557
24. Pariante CM, Papadopoulos AS, Poon L, Cleare AJ, Checkley SA, English J, Kerwin RW, Lightman S (2004) Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers. Psychopharmacology (Berl) 177(1-2):200-206
25. Pinborg LH, Adams KH, Yndgaard S, Hasselbalch SG, Holm S, Kristiansen H, Paulson OB, Knudsen GM (2004) [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. J Cereb Blood Flow Metab 24(9):1037-1045
26. Raap DK, Van de Kar (1999) Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 65(12):1217-1235
27. Shlik J, Maron E, Tru I, Aluoja A, Vasar V (2004) Citalopram challenge in social anxiety disorder. Int J Neuropsychopharmacol 7(2):177-182
28. Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 44(11):946-951